Intraocular pressure derailment, hyphema and uveitis in chronic lymphocytic leukemia with ibrutinib therapy

被引：0
|
作者：
Assaf, Abdelrahman [1 ]
Aghayeva, Fidan [2 ]
Lanzl, Ines M. [3 ]
机构：
[1] Tech Univ Munich, Klinikum Rechts Isar, Med Klin 2, Munich, Germany
[2] Chiemsee Augentagesklin, Prien Am Chiemsee, Germany
[3] Tech Univ Munich, Klin & Poliklin Augenheilkunde, Klinikum rechts Isar, Munich, Germany
来源：
OPHTHALMOLOGIE | 2025年
关键词：
D O I：
10.1007/s00347-025-02208-8
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [41] NAIL AND HAIR CHANGES DURING IBRUTINIB THERAPY IN CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS
    Mauro, F. R.
    Porrazzo, M.
    Bottoni, U.
    Riemma, C.
    Raponi, S.
    Guarini, A.
    Foa, R.
    HAEMATOLOGICA, 2017, 102 : 122 - 122
  • [42] Atypical primary cutaneous cryptococcosis during ibrutinib therapy for chronic lymphocytic leukemia
    Anna Maria Peri
    Raffaella Rossio
    Francesco Tafuri
    Valentina Benzecry
    Anna Grancini
    Gianluigi Reda
    Alessandra Bandera
    Flora Peyvandi
    Annals of Hematology, 2019, 98 : 2847 - 2849
  • [43] Ibrutinib therapy downregulates AID enzyme and proliferative fractions in chronic lymphocytic leukemia
    Morande, Pablo Elias
    Sivina, Mariela
    Uriepero, Angimar
    Seija, Noe
    Berca, Catalina
    Fresia, Pablo
    Landoni, Ana Ines
    Di Noia, Javier M.
    Burger, Jan A.
    Oppezzo, Pablo
    BLOOD, 2019, 133 (19) : 2056 - 2068
  • [44] Management of patients with chronic lymphocytic leukemia at high risk of relapse on ibrutinib therapy
    Ayed, Ayed O.
    Parikh, Sameer A.
    LEUKEMIA & LYMPHOMA, 2018, 59 (10) : 2287 - 2296
  • [45] Atypical primary cutaneous cryptococcosis during ibrutinib therapy for chronic lymphocytic leukemia
    Peri, Anna Maria
    Rossio, Raffaella
    Tafuri, Francesco
    Benzecry, Valentina
    Grancini, Anna
    Reda, Gianluigi
    Bandera, Alessandra
    Peyvandi, Flora
    ANNALS OF HEMATOLOGY, 2019, 98 (12) : 2847 - 2849
  • [46] Ibrutinib-Based Therapy in the Treatment of Relapsed and Refractory Chronic Lymphocytic Leukemia
    Kuvshinov, Alexey
    Voloshin, Sergei
    Martynkevich, Irina
    Martynenko, Ludmila
    Garifullin, Andrei
    Kleina, Elizaveta
    Shuvaev, Vasily
    BLOOD, 2016, 128 (22)
  • [47] Leukemia cell proliferation and death in chronic lymphocytic leukemia patients on therapy with the BTK inhibitor ibrutinib
    Burger, Jan A.
    Li, Kelvin W.
    Keating, Michael J.
    Sivina, Mariela
    Amer, Ahmed M.
    Garg, Naveen
    Ferrajoli, Alessandra
    Huang, Xuelin
    Kantarjian, Hagop
    Wierda, William G.
    O'Brien, Susan
    Hellerstein, Marc K.
    Turner, Scott M.
    Emson, Claire L.
    Chen, Shih-Shih
    Yan, Xiao-Jie
    Wodarz, Dominik
    Chiorazzi, Nicholas
    JCI INSIGHT, 2017, 2 (02):
  • [48] Impact of Ibrutinib Dose Reduction on Duration of Therapy in Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
    Shadman, Mazyar
    Karve, Sudeep
    Patel, Sima
    Rava, Andrew
    Sun, Haiyan
    Howarth, Amanda
    Tomicki, Samantha
    Srivastava, Bhavini P.
    Stephens, Deborah M.
    BLOOD, 2023, 142
  • [49] Ibrutinib in chronic lymphocytic leukemia and B cell malignancies
    Brown, Jennifer R.
    LEUKEMIA & LYMPHOMA, 2014, 55 (02) : 263 - 269
  • [50] IBRUTINIB: NEW TARGET TREATMENT IN CHRONIC LYMPHOCYTIC LEUKEMIA
    Torres Iglesias, C.
    Torres Carrete, J. P.
    Vale Lopez, A.
    Deben Ariznavarreta, G.
    Noriega Concepcion, V
    Varela Gomez, R.
    Martinez Senaris, D.
    Martinez Gomez, C.
    Hevilla Carmona, A.
    Lopez Fernandez, F.
    HAEMATOLOGICA, 2019, 104 : 433 - 433
12345